| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_772bf43736680605c5adfbf2a5070372 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
2013-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4f64069e3af58f637b0be95e333aba7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca8da5bf05d415573358274a1901d26c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2b576816cfeec97a2d3844b9a4c68f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb6f57a6c26dc1a2d7d1551f923487d9 |
| publicationDate |
2013-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2664920-A1 |
| titleOfInvention |
Dilution based inhibition assay |
| abstract |
The present invention provides for a process to assess the level of reversible inhibition of an enzyme by an inhibitor, in particular in the field of assessment the effectiveness of a medical treatment. In a particularly preferred embodiment the effectiveness of angiotensin converting enzyme (ACE) inhibitor (ACEi) therapy is disclosed. The invention also relates to uses of enzyme substrates and kits for the assessment of inhibition level as well as an apparatus designed for use in a process of the present invention. |
| priorityDate |
2012-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |